Navigation Links
Orexigen® Therapeutics Reports Second Quarter Ended June 30, 2011 Financial Results
Date:8/8/2011

rm debt, current portion

2052,416Total current liabilities

9,23416,288Deferred revenue, less current portion

43,71446,311Other long-term liabilities

383459Commitments and contingenciesStockholders’ equity:Preferred stock, $.001 par value, 10,000,000 shares authorized at June 30, 2011 and December 31, 2010; noshares issued and outstanding at  June 30, 2011 and December 31, 2010--Common stock, $.001 par value, 300,000,000 and  100,000,000 shares authorized at June 30, 2011 and  December 31, 2010;48,084,692 and 47,767,313 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively

4848Additional paid-in capital

356,722352,401Accumulated other comprehensive income (loss)

6(9)Accumulated deficit

(337,823)(318,652)Total stockholders’ equity

18,95333,788Total liabilities and stockholders’ equity

$
72,284$
96,846
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Orexigen® Therapeutics Announces FDA Acceptance of Contrave® New Drug Application for the Treatment of Obesity
2. Orexigen® Therapeutics Schedules August 5, 2010 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2010
3. Orexigen® Therapeutics Announces Publication of COR-I Phase 3 Study of Contrave in Lancet
4. Orexigen® Therapeutics COR-BMOD Study Published in the Journal Obesity
5. Orexigen® Therapeutics and Takeda Enter Into Partnership to Commercialize Contrave® in North America
6. Orexigen® Therapeutics to Speak at Rodman & Renshaw Annual Global Investment Conference
7. Orexigen® Therapeutics to Speak at Fifth Annual JMP Securities Healthcare Conference
8. Orexigen® Therapeutics Reports Third Quarter 2010 Financial Results
9. Orexigen® Therapeutics Investigational Drug Contrave® Receives Positive Recommendation from FDA Advisory Committee for Treatment of Obesity
10. Orexigen® Therapeutics, Inc. Announces Upcoming Departure of Chief Financial Officer
11. Orexigen® Therapeutics Schedules March 10, 2011 Webcast Discussion of Financial Results for the Fourth Quarter and Year Ended December 31, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/zkkg9q/blood_processing ) has announced ... - Global Strategic Business Report" report to their offering. ... US, Canada , Japan ... , Latin America , and Rest of ... 2014 through 2020. Also, a seven-year historic analysis is provided ...
(Date:6/2/2015)... June 02, 2015 Research and Markets ( http://www.researchandmarkets.com/research/g5r2nj/surgical_incision ... Closures - Global Strategic Business Report" report to their ... the US, Canada , Japan ... , Latin America , and Rest ... for Surgical Incision Closures in US$ Million by the following ...
(Date:6/2/2015)... BOSTON , June 2, 2015 ... an additional $75 million from its recently announced synthetic ... raised to $300 million. Investors have purchased Convertible Limited ... quarterly payments equal to 2.0% of any future global ... or are fully paid. Investors also have the option, ...
Breaking Medicine Technology:Blood Processing Supplies and Equipment Market - Global Strategic Business Report 2015-2020 2Blood Processing Supplies and Equipment Market - Global Strategic Business Report 2015-2020 3Surgical Incision Closures - Global Strategic Business Report 2015 2Intarcia Exercises Re-Opener For Its Recently Closed Royalty / Equity Convert Financing - Raising Total To $300 Million 2Intarcia Exercises Re-Opener For Its Recently Closed Royalty / Equity Convert Financing - Raising Total To $300 Million 3
(Date:6/3/2015)... Veatch Consulting Services is excited to announce their achievement ... in April 2006, they have made it a priority ... and every year they have worked diligently in surpassing ... that they are off to a great start already ... year is the Customer Review site veatchconsultingreviews.weebly.com. At this ...
(Date:6/2/2015)... BALTIMORE, Md. – Ellarea Maria Cole Stansbury ... after being diagnosed with lupus. In spite of genetic ... which enhance health, lupus and other autoimmune related diseases ... Wellness ,” she offers a holistic approach to live ... an overview of some autoimmune diseases—especially lupus —including ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Concorde Career ... as President and COO. Bell will manage day-to-day operations ... “I’m looking forward to the opportunity to help our ... Bell said. “I joined Concorde in part due to ... that highlighted Concorde colleges in Memphis and Portland.” , ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 April 8th, ... music venue into Durkin Entertainment’s “RockNRolla Movie Awards” EcoLuxe ... Bend, that gathered some of the world’s top providers ... The event was organized by Debbie Durkin, Los Angeles’ ... film, the EcoLuxe Lounge is a premier red carpet ...
(Date:6/2/2015)... Residents looking for a new dentist ... more convenient location now that Coast Dental Kissimmee is ... E. Irlo Bronson Memorial Highway, Suite C-106, Kissimmee, FL ... mile away from its original location, and features a ... areas with digital intraoral and panoramic x-ray system and ...
Breaking Medicine News(10 mins):Health News:Veatch Consulting Services Is Breaking New Ground in Customer Satisfaction 2Health News:Veatch Consulting Services Is Breaking New Ground in Customer Satisfaction 3Health News:New book offers holistic approach in living with autoimmune diseases 2Health News:New book offers holistic approach in living with autoimmune diseases 3Health News:Concorde Career Colleges Announces New President and COO 2Health News:Choices Recovery South Bend Discusses Addiction With Rising Hollywood Star Ben Stillwell 2Health News:Coast Dental Office Opening In Kissimmee with Expanded Technology 2
... in the March 2006 issue of Archives of Ophthalmology says ... risk of relapse of a vision-threatening eyelid condition called trichiasis.// ... clinical trial funded by the National Eye Institute (NEI), part ... ,It was found that azithromycin was better than the local ...
... Medicine in St. Louis say that a noninvasive approach ... developing drugs for cystic fibrosis and pneumonia. // Positron ... induced inflammation in the lungs of healthy volunteers. ... a new drug decreased lung inflammation, the options for ...
... you can’t wait for a appointment a local clinic now ... clear results in 10 minutes//, ,Chlamydia is the most ... no symptoms, and can be passed on to others without ... including problems in pregnancy and infertility in both men and ...
... long term will make the brain to lose its ability, gradually ... led by Lambros Messinis at the University Hospital of Patras in ... taken marijuana heavily. They smoked at least four joints a week ... New Scientist. ,Their brains were rustier than those ...
... is found to improve their kidney function in patients with heart ... he said that those patients who took 80 mg of the ... ,The drug is the world's top-selling prescription drug. The data of ... scientific meeting in Atlanta. ,50% of the patients, who ...
... Jordan said that the kingdom was untouched by the avian flu ... the joint effort of both the public and the government. He ... in the country. , The minister made the ... , In that occasion to celebrate this great achievement the ...
Cached Medicine News:Health News:Home Chlamydia Test 2
... Left Ventricular Assist System (LVAS) is a ... restore hemodynamic function and improve patient outcomes ... action of a single-moving part, the HeartMate ... support by pumping blood from the heart ...
... standard to extra-wide wheelchairs (18" to 43") ... heavy-duty, anodized aluminum weighing platform is equipped ... easy access for large patients. Weight is ... readout. The 6772 has the unique features ...
... Bariatric Stand-On Scale is designed to accommodate ... physicians scales only weigh up to 300 ... surface, or patients position on the scale., ... profile only 1 1/4 inches high. ...
... hormone (PTH) is synthesized by the ... response to decreased extracellular calcium concentrations. ... resorption and decreasing calcium excretion by ... circulation, intact PTH is rapidly degraded ...
Medicine Products: